Didier has a Master's degree in Biology & Engineering and an agrégation (high-level teaching examination) in Chemistry.
In 1992, after a few months of teaching and military service, Didier joined a Belgian distributor of high-tech scientific instruments as Sales engineer. After a few months he created and led a Business Unit focused on Inorganic analysis by spectrometry.
In 2002, he was hired as Sales Manager by 4Cbiotech, a Belgian contract bio manufacturing company, which was bought by Henogen a year later, a major player in the same field.
Having created and led a logistics and cGMP production team, Didier headed the procurement and business development departments at Henogen-Novasep until August 2010.
Recruited at that time by Wallonia Biotech (Brussels University) as the cell therapy platform Project Leader, Didier co-founded MasTherCell in November 2011, in which he was Chief Business Officer and board member until August 2012 when he created Biotech Consult scs.
Since October 2012, Didier has been working for Bioptis (via the Wallonia Biotech Coaching) active in the field of regenerative medicine applied to equine articular pathologies : market research and spin-off incorporation.